Freenome

Freenome
Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
About
What does Freenome do?
Freenome is a biotechnology company dedicated to outpacing cancer through early detection. Their intelligent screening platform utilizes multiomics technology and artificial intelligence, combined with a standard blood draw, to identify cancer in its earliest, most treatable stages. This approach aims to make a significant difference by enabling earlier intervention and improving patient outcomes.
What is Freenome's revenue?
StartupHub estimates Freenome's annual revenue at $41.7M (range $22.3M to $135.5M, 68% confidence), based on comparable companies in the sector.
What is Freenome's valuation?
StartupHub estimates Freenome's effective valuation at $563.3M (range $394.3M to $732.2M, 27% confidence), based on comparable companies in the sector.
How much funding has Freenome raised?
Freenome has raised a total of $570M in funding. The most recent round on record is Series D.
Where is Freenome headquartered?
Freenome is headquartered in South San Francisco, California, USA.
When was Freenome founded?
Freenome was founded in 2014.
What industry does Freenome operate in?
Freenome operates in Biotechnology, Healthcare, Artificial Intelligence, Biotech, MedTech, HealthTech.
How many employees does Freenome have?
Freenome has approximately 402 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.
